{
    "clinical_study": {
        "@rank": "143059", 
        "arm_group": {
            "arm_group_label": "Indocyanine green & methylene blue,", 
            "arm_group_type": "Experimental", 
            "description": "Subcutaneous injection around the areola with 2-4 points Methylene blue with 1ml of 1% Indocyanine green with 1ml of 0.5%"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the sentinel lymph node (SLN) detection rate of\n      early breast cancer patients between using Indocyanine green (ICG) and Methylene blue with a\n      novel surgical navigation system."
        }, 
        "brief_title": "Application of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer Research", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Detection Rate", 
            "Sentinel Lymph Node", 
            "Breast Cancer", 
            "Indocyanine Green.", 
            "Methylene Blue"
        ], 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria: (Before the test, all the subjects required for meeting the entry\n        requirements before they join the group)\n\n          -  female patients;\n\n          -  The preoperative core needle biopsy or open surgical excision biopsy diagnosis as\n             breast cancer;\n\n          -  tumor diameter \u2264 3cm;\n\n          -  No clinical examination of suspicious axillary lymph node-positive;\n\n          -  diagnosed clinical conditions can be directly surgery as I, II breast cancer\n             patients;\n\n          -  preoperative clinical or radiologic evidence without distant metastases (M0);\n\n          -  signed informed consent.\n\n        Exclusion criteria: (Before the test, the subjects under any one of items to meet the\n        requirements can not be enrolled)\n\n          -  Sentinel lymph node biopsy history had received surgery or axillary area;\n\n          -  multi-center breast cancer or multiple lesions;\n\n          -  clinical axillary lymph node metastasis have been found;\n\n          -  mammary area had received neoadjuvant chemotherapy or radiotherapy;\n\n          -  inflammatory breast cancer;\n\n          -  pregnancy;\n\n          -  no personal freedom and independent civil capacity.\n\n        Exclusion criteria: (trials, subjects necessary to meet the requirements of any one item,\n        exit the clinical trial research.)\n\n          -  severe allergic reaction occurs;\n\n          -  persistent allergic reaction;\n\n          -  subjects were required to withdraw from a clinical trial;\n\n          -  researchers consider it not appropriate to continue to participate in the clinical\n             trial investigator."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02084784", 
            "org_study_id": "2011CB707700", 
            "secondary_id": "973"
        }, 
        "intervention": [
            {
                "arm_group_label": "Indocyanine green & methylene blue,", 
                "intervention_name": "Indocyanine green", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Indocyanine green & methylene blue,", 
                "intervention_name": "methylene blue", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methylene Blue"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Near-infrared fluorescence", 
            "Image guided surgery", 
            "Breast cancer;", 
            "Sentinel lymph node biopsy", 
            "Indocyanine green", 
            "Methylene blue"
        ], 
        "lastchanged_date": "March 24, 2014", 
        "link": {
            "description": "A Website from Key Laboratory of Molecular Imaging, Chinese Academy of Sciences", 
            "url": "http://www.mitk.net/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100190"
                }, 
                "name": "Key Laboratory of Molecular Imaging, Chinese Academy of Sciences"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Study of Surgical Navigation System in Detection of Sentinel Lymph Node of Early Breast Cancer Patients", 
        "overall_official": {
            "affiliation": "Key Laboratory of Molecular Imaging, Chinese Academy of Sciences", 
            "last_name": "Chongwei Chi, doctor", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Participants will be followed for the duration of hospital stay, an expected average of 1 year", 
            "measure": "Sentinel lymph node detection rate", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02084784"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chinese Academy of Sciences", 
            "investigator_full_name": "Chongwei Chi, Ph.D", 
            "investigator_title": "Key Laboratory of Molecular Imaging, Chinese Academy of Sciences", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "24358319", 
            "citation": "Chi C, Ye J, Ding H, He D, Huang W, Zhang GJ, Tian J. Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation. PLoS One. 2013 Dec 16;8(12):e83927. doi: 10.1371/journal.pone.0083927. eCollection 2013."
        }, 
        "source": "Chinese Academy of Sciences", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Chinese PLA General Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Cancer Hospital of Shantou University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Yijishan Hospital of Wannan Medical College", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Chinese Academy of Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}